Citation Impact
Citing Papers
High-Throughput Screens for Small-Molecule Inhibitors of Pseudomonas aeruginosa Biofilm Development
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
First Nosocomial Outbreak of Pseudomonas aeruginosa Producing an Integron-Borne Metallo-β-Lactamase (VIM-2) in the United States
2005
Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)
2006
Structure of the O6 antigen of Stenotrophomonas (Xanthomonas or Pseudomonas) maltophilia
1995
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004
2005
Establishing the Diagnosis of Lung Cancer
2013 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Comparison of Treatment with Imipenem vs. Ceftazidime as a Predisposing Factor for Nosocomial Acquisition of Stenotrophomonas maltophilia: A Historical Cohort Study
1997
Novel Mechanism of Hydrolysis of Therapeutic β-Lactams byStenotrophomonas maltophilia L1 Metallo-β-lactamase
2001
In Vitro Activity of β-Lactam Antimicrobial Agents in Combination with Aztreonam Tested Against Metallob-β-Lactamase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii
2005
Activity of trimethoprim/ sulfamethoxazole plus polymyxin B against multiresistantStenotrophomonas maltophilia
1996
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation
2005
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Successful Treatment of Rhinocerebral Mucormycosis with Liposomal Amphotericin B and Surgery in Two Diabetic Patients with Renal Dysfunction
2003
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients
2003
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
2006
Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA
2007
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003)
2004
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States
2003
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer
1997
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
2004
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study
2003
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
2007
Initial Diagnosis of Lung Cancer
2007
Stopping Antibiotic Therapy in Neutropenic Patients
1988
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
ADVANCES IN MEDICAL AND ANTIBIOTIC MANAGEMENT OF INFECTIVE ENDOCARDITIS
1996
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
2006
Efficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with Cancer
2006
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Catalytic Enantioselective 1,6‐Conjugate Addition of Grignard Reagents to Linear Dienoates
2007 StandoutNobel
Structure of the O10 antigen of Stenotrophomonas (Xanthomonas) maltophilia
1995
Economic and Resource Utilization Analysis of Outpatient Management of Fever and Neutropenia in Low-Risk Pediatric Patients With Cancer
1999
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam
1994
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient
1996
Allergic Rhizomucor sinusitis
1992
Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
2007
The Science of Antibiotic Discovery
2020 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Structure of the O3 antigen of Stenotrophomonas (Xanthomonas or Pseudomonas) maltophilia
1996
Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients
1993
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
2005
Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
2006
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Glucocorticoids and invasive fungal infections
2003
Septic Prepatellar Bursitis Caused by Stenotrophomonas (Xanthomonas) maltophilia
1996
Emerging Infections: Adenovirus Infections in Transplant Recipients
2006
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*
2007
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
2000
Bacterial infections in low‐risk, febrile neutropenic patients
2005
Is Monotherapy for Febrile Neutropenia Still a Viable Alternative?
1999
Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery
2005
Infections due to emerging and uncommon medically important fungal pathogens
2004
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients
2000
Bacteremia Due to Stenotrophomonas (Xanthomonas) maltophilia: A Prospective, Multicenter Study of 91 Episodes
1996
Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial
1999
Microbiological Features of Vancomycin in the 21st Century: Minimum Inhibitory Concentration Creep, Bactericidal/Static Activity, and Applied Breakpoints to Predict Clinical Outcomes or Detect Resistant Strains
2005
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer
2002
Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility
2000
Quantitative Real‐Time Polymerase Chain Reaction for Detection of Adenovirus after T Cell–Replete Hematopoietic Cell Transplantation: Viral Load as a Marker for Invasive Disease
2007
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Oral administration of cefixime to lower risk febrile neutropenic children with cancer
2000
Structure of the O2 antigen of Stenotrophomonas (Xanthomonas or Pseudomonas) maltophilia
1997
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
1998
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Vancomycin as Part of Initial Empirical Antibiotic Therapy for Febrile Neutropenia in Patients with Cancer: Pros and Cons
1999
A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile Neutropenia
2001
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients
1998
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
2019
Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients
1997
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Zygomycosis (mucormycosis): emerging clinical importance and new treatments
2004
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated Pathogens
2004
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
1995
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
An analysis of interleukin-8, interleukin-6 and C-Reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients
1998
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
2006
Cure of Pulmonary Rhizomucor Pusillus Infection in a Patient with Hairy-Cell Leukemia: Role of Liposomal Amphotericin B and GM-CSF
2001
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome
2003
Mucormycosis in systemic lupus erythematosus
2003
In vitro activites of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood
1995
Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia
1996
Improved survival of critically ill cancer patients with septic shock
2003
Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients
2006
The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia
1995
Invasive adenoviral infections in T‐cell‐depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir
2007
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
2006
Treatment of febrile neutropenic patients with cancer who require hospitalization
2003
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Vancomycin does not benefit persistently febrile neutropenic people with cancer
2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
2004
Stenotrophomonas maltophilia Ocular Infections
1996
Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy
2007
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Zygomycosis
2002
Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases
2005
The treatment of febrile neutropenia: from the Dark Ages to the present
1997
Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir
2007
Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.
1997
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Polyomavirus BK
2003
Prediction of Gram-Negative Bacteremia in Patients with Cancer and Febrile Neutropenia by Means of Interleukin-8 Levels in Serum: Targeting Empirical Monotherapy versus Combination Therapy
2001
Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum
2006
Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients
2001
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy
1999
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
2006
Bacteraemia in febrile neutropenic cancer patients
2007
The New β-Lactamases
2005
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model
1996
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia
1995
Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical Testing
2002
Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis
2004
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial
2000
The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly
2018
Isolation of an Integron-Borne bla VIM-4 Type Metallo-β-Lactamase Gene from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate in Hungary
2004
Synthesis of (3S,5R)-Carbapenam-3-carboxylic Acid and Its Role in Carbapenem Biosynthesis and the Stereoinversion Problem
2003
Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens
1995
How should imipenem-cilastatin be Used in the treatment of fever and infection in neutropenic cancer patients?
1998
Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens
2002
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group
1991
Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro
1992
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
1996
Carbapenem Biosynthesis: Confirmation of Stereochemical Assignments and the Role of CarC in the Ring Stereoinversion Process from l -Proline
2003
Prevention and Treatment of Cancer-Related Infections
2012
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients
1997
Non-Heme Fe(IV)–Oxo Intermediates
2007 Standout
Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia
1995
On the Mechanism of Cu-Catalyzed Enantioselective Extended Conjugate Additions: A Structure-Based Approach
2014 StandoutNobel
Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo-β-Lactamase Family
2008
Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa
2006
First Reported Outbreak of Diarrhea Due to Adenovirus Infection in a Hematology Unit for Adults
2005
Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients Using a Score Predictive for Complications
2006
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Diagnostic Value of Procalcitonin Serum Levels in Neutropenic Patients with Fever: Comparison with Interleukin-8
1999
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
1999
First Detection of Metallo-β-Lactamase VIM-2 in Pseudomonas aeruginosa Isolates from Colombia
2005
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Management of Fever in Neutropenic Patients with Different Risks of Complications
2004
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
2002
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey
2002
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem
1996
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
2006
Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia
1994
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
2021 StandoutNobel
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Time to Clinical Response: An Outcome of Antibiotic Therapy of Febrile Neutropenia With Implications for Quality and Cost of Care
2000
bla VIM-2 and bla VIM-7 Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program
2006
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
2008
Short-Course Gentamicin in Combination with Daptomycin or Vancomycin against Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2005
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Catalytic Asymmetric Conjugate Addition and Allylic Alkylation with Grignard Reagents
2008 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2008
Metallo-β-Lactamases: the Quiet before the Storm?
2005
Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review
2007
Organocatalytic Asymmetric 1,6-Additions of β-Ketoesters and Glycine Imine
2007
In Vitro Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent
2005
Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia
1997
Multiple antibiotic resistance in Stenotrophomonas maltophilia
1997
Respiratory Virus Infections in Adults with Hematologic Malignancies: A Prospective Study
2003
Amino Acid Sequence Requirements at Residues 69 and 238 for the SME-1 β-Lactamase To Confer Resistance to β-Lactam Antibiotics
2003
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)
1998
In vitrosusceptibility of 124Xanthomonas maltophilia(Stenotrophomonas maltophilia) isolates
1996
Origins and Evolution of Antibiotic Resistance
2010 Standout
Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program
2004
Carbapenemases: Molecular Diversity and Clinical Consequences
2007
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease
2003
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients Using a Score Predictive for Complications
2008
Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa
2002
Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated.
1996
Works of Kenneth Rolston being referenced
Adenovirus Infections in Adult Recipients of Blood and Marrow Transplants
2001
Carbapenems in clinical practice: a guide to their use in serious infection
1999
Pulmonary infections mimicking cancer: A retrospective, three-year review
1997
The Importance of Bactericidal Drugs: Future Directions in Infectious Disease
2004
Cryptococcosis in Patients with Cancer
2001
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients
1996
Outpatient management of febrile episodes in neutropenic cancer patients
1994
Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials
1997
Recent Experience With Pseudomonas aeruginosa Bacteremia in Patients With Cancer
2000
EARLY EMPIRIC ANTIBIOTIC THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW RISK
1996
Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancer
2005
Culture-Positive and Culture-Negative Endocarditis in Patients With Cancer
2006
Epidemiology and outcomes of serious influenza‐related infections in the cancer population
2005
A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients
1992
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy
1994
Imipenem-cilastatin as initial therapy for febrile cancer patients
1986
Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer
1990
In vitro susceptibility of Acinetobacter species to various antimicrobial agents
1986
Infections Caused by Drechslera Species: Case Report and Review of the Literature
1985
In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer
1993
bla VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States
2003
Zygomycosis in the 1990s in a Tertiary-Care Cancer Center
2000